Clinical Trial

SPYRAL GEMINI Pilot Study

Name: SPYRAL GEMINI Pilot Study — clinical trial record (NCT06907147)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: SPYRAL GEMINI

Recruiting

View on ClinicalTrials.gov →

Summary

The purpose of the SPYRAL GEMINI Pilot Study is to evaluate that multi-organ denervation with the Gemini System is safe and provide evidence of blood pressure reduction when studied in an uncontrolled hypertensive population with and without high cardiovascular risk.

Protocol Amendment History 1 change

notable Trial sites expanded: 13 -> 16 locations 2026-05-15

Trial Details

NCT Number	NCT06907147
Lead Sponsor	Medtronic Vascular
Conditions	Hypertension, Vascular Diseases, Cardiovascular Diseases, Chronic Kidney Diseases, Diabetes Mellitus
Enrollment	175 participants
Start Date	2025-05-01
Primary Completion	2029-12-22 (estimated)
Study Completion	2029-12-22 (estimated)
Updated on ClinicalTrials.gov	2026-06-24